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Cytokine.activated human mesangial cells generate the neutrophil
chemattractant, interleukin 8. Human mesangial cells (MC) in culture,
when stimulated by interleukin 1 a(IL- I a) or tumour necrosis factor
(TNFa), but not with lipopolysaccharide (LPS), express interleukin 8
(IL-8) mRNA, and both cell associated and extracellular IL-8. Dexa-
methasone treatment of mesangial cells induced partial inhibition of the
release of extracellular IL-8, while cell-associated IL-8 and IL-8 mRNA
were not significantly altered. We propose that the mesangial cell has a
direct role in the initiation and propagation of inflammatory events
within the glomerulus via the generation of the chemotactic cytokine
IL-8.
The location and properties of the glomerular mesangial cells
confer a central role for these cells in the regulation of renal
function [1]. In a number of disease states renal function is
compromised as a result of glomerulonephritis [1]. This disease
state is associated with an influx of neutrophils and mononu-
clear cells [21. While the mechanism(s) by which these specific
cells are recruited remains poorly understood, there is indirect
evidence to suggest that the glomerular mesangial cells partic-
ipate in this inflammatory process [1].
Interleukin 8 (IL-8) is a novel chemotactic cytokine, which
was initially isolated from LPS stimulated human peripheral
blood monocytes [3, 4]. In addition, non-immune cells such as
fibroblasts, endothelial and epithelial cells can generate IL-8 in
response to the cytokines IL-la and TNFa [3]. Interleukin-8 is
a potent chemotactic agent and activator of neutrophils [4, 5] as
well as being a very potent chemoattractant for lymphocytes [6,
71. Thus these properties, cellular sources, and specificity of
induction strongly suggest that IL-8 is a local inflammatory
mediator.
We demonstrate here that cultured human mesangial cells in
response to IL-la or TNFa, but not LPS, express IL-8 mRNA
and cell associated IL-8. In addition, IL-la, and to a lesser
extent TNFa, induce a dose- and time-dependent release of
IL-8 from mesangial cells. Furthermore, dexamethasone treat-
ment of MC before stimulation with IL-I a or TNFa results in a
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Human recombinant IL-la (specific activity 2.1 x iO U/mg)
and human recombinant TNFa (specific activity of 6 X l0
U/mg), were from Hoffman La Roche and Ernst-Boehringer,
respectively. All culture reagents (endotoxin free) and plastics
were from Gibco and Nunc, respectively; LPS (E. coliOlll:B4)
and dexamethasone were supplied by Difco and Sigma Ltd.
Mesangial cell preparation and culture conditions
Portions of macroscopically normal renal cortex were ob-
tained from human kidneys immediately after surgical nephrec-
tomy for renal carcinoma. Human MC were obtained from
glomeruli isolated by differential sieving and collagenase-treat-
ment as described by Striker and Striker [81, and Lovett, Ryan
and Sterzel [9]. Primary cultures were established as out-
growths from glomeruli by day 10 and proliferated to conflu-
ency by day 20. Subsequently cell cultures were maintained in
Waymouth's MB752/1 supplemented with 15% heat-inactivated
fetal calf serum (complete MC-medium); all cells in these
studies were used between passage 2 and 6. Mesangial cell
identity was confirmed by using the following criteria: immu-
nofluorescence staining of both primary and passaged MC
revealed uniform and prominent intracellular longitudinal fibrils
form smooth muscle actin (phalloidin-FITC, Sigma), as well as
for vimentin, desmin and fibronectin (monoclonal antibodies,
supplied by Dr. S. Kelly). In addition, mesangial cells displayed
the characteristic hillock structures in culture as described by
Sterzel et al [10], while cells stained with antibodies using the
immunoperoxidase method were negative for von Willebrand
factor antigen (Dako), Ulex Europaeus lectin 1 (Sigma), and
cytokeratin (monoclonal 8.13, from Sigma), thus excluding
contamination with endothelial and epithelial cells, respec-
tively. Electron microscopy of cell cultures revealed the pres-
ence of prominent bundles of peripheral microfilaments with
focal attachment bodies (dense bodies) along their course, a
feature which is associated with mesangial and smooth muscle
cells and is absent in fibroblasts [11].
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Fig. 1. Dose-dependent induction of IL-8
generation by LPS, TNFa and IL-la treated
mesangial cells. The mesangial cells were
challenged with the appropriate doses of IL-I a,
TNFa, LPS or vehicle control for 24 hours and
the supernatants were quantitated for
extracellular IL-8 activity. Data shown are from a
representative experiment, similar results were
C 0.3 3.0 30 obtained in 3 other experiments (all experiments
were carried out in duplicate). Results are the
mean SEM of quadruplet samples.
Mesangial cells (5 x 105/well) were plated on to gelatin
(endotoxin free, Sigma) coated 24-macrowell tissue culture
plates. Twenty-four hours before stimulation confluent cell
cultures were washed and cultured in serum-free medium
(without fetal calf serum or growth factors). The following day
cells were treated with fresh serum-free medium and challenged
with cytokines, LPS or vehicle control for the specified times
and doses.
Enzyme linked immunoadsorbent (ELISA) for IL-8
Extraceilular IL-8 activity of culture supernatants was mea-
sured using a double ligand ELISA method, as previously
described [12, 13]. The detection limit of this assay is 300 pg/mI.
Goat-antihuman-IL-8, human recombinant IL-8 and anti-IL-8-
Biotin conjugate were supplied by Sandoz, Forschungsinstitut,
Vienna, Austria. Avidin horseradish peroxidase enzyme conju-
gate and peroxidase substrate were from Bio Rad, Ltd.
Northern blot analysis
Total cellular RNA from mesangial cells was isolated using a
modification of the method of Chirgwin et al [14] and Jonas,
Sargent and Davis [15]. RNA from MC was extracted and
separated by Northern blot analysis using the method described
by Strieter et al [16]. Briefly, mesangial cells were scraped from
flasks in a solution consisting of 25 mri Tris, pH 8.0 containing
4.2 M guanidine isothiocyanate, 0.5% Sarkosyl, and 0.1 M
2-mercaptoethanol. After homogenization, the above suspen-
sion was added to an equal volume of 100 mM Tris pH 8.0
containing 10 mrt EDTA and 1.0% SDS. The mixture was then
extracted with chloroform-phenol and chloroform-isoamyl al-
cohol. The RNA was alcohol-precipitated and the pellet dis-
solved in 10 m Tris, 0.1 m EDTA buffer with 0.1% Sarkosyl.
The concentration of RNA was determined by obtaining the
absorbance at A2 and A280 nm, so that 10 jsg of RNA was
loaded in to each well of the agarose gel. RNA was separated by
Northern blot analysis using formaldehyde, 1% agarose gels,
transblotted to nitrocellulose, baked prehybridized, and hybrid-
ized with a 32P 5'-end labelled oligonucleotide probe. The 30
mer oligonucleotide probe was complementary to nucleotides
262—291 of IL-8 mRNA and had the sequence of 5'-G'IT-GGC-
GCA-GTG-TGG-TCC-ACT-CTC-AAT-CAC-3' [17]. Blots
were quantitated using laser densitometry [13, 16]. Equivalent
amounts of total RNA load per gel lane was assessed by
monitoring 1SS and 28S RNA.
Immunohistochemistry
Mesangial cells were assessed for the expression of antigenic
IL-8 as previously published [13]. Following treatment, slides
were fixed with 4% paraformaldehyde in phosphate-buffered
saline pH 7.4 (PBS) for 15 minutes at room temperature, and
then washed three times with PBS. Prior to staining, the slides
were fixed, cells were then treated with a 1:2000 dilution of
either control (rabbit) or rabbit-antihuman IL-8 serum. Anti-
genic IL-8 was detected using a biotinylated goat-antirabbit
IgG/streptavidin peroxidase conjugate system. Competitive in-
hibition studies to demonstrate IL-8 antibody specificity re-
vealed 100% inhibition of exogenously added rIL-8.
Results
Extracellular generation of IL-8 by IL-la and TNFa
stimulated mesangial cells
Supernatants derived from mesangial cells cultured in the
presence of serum-free medium alone did not contain detectable
levels (<300 pg/mI) of IL-8 at 1, 3, 5, 8 and 24 hours. The
addition of IL-la (0.3 to 30 ng/ml) produced a dose dependent
release of IL-8 (Fig. 1). Similarly, the addition of TNFa
produced a marked increase in the generation of IL-8, although
TNF was approximately 300-fold less potent than IL-la (Fig.
1). In contrast, incubation of MC with LPS (0.1 to 10 /ml) for
24 hours did not produce detectable level of extracellular IL-8.
Addition of sub-optimal doses of either IL-i a (3 ng/ml) or
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2) IL-la (30 ng/ml) 6 hr
3) LPS (lOp.g/ml) 6 hr
4) Dex 2 hr (300 flM), 6 hr IL-la
5) Dex 2 hr (300 nM), 6 hr vehicle
6) Vehicle 2 hr. 6 hr IL-la
—1 8S
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Fig. 2. Expression of IL-8 mRNA by mesangial cells. Human mesan-
gial cells were treated with either IL-la (30 ng/ml), LPS (10 sg/m1) or
vehicle control and total RNA was extracted 6 hours post-challenge
(lanes 1-3), A. The Northern blot of the IL-8 mRNA, laser densitometry
of each respective Northern blot panel B, (AU mm = is the actual
absorbance of the density of the autoradiography for each of the bands
of mRNA determined by the laser per mm), and 28S and l8S ribosomat
RNA (C) demonstrating equal loading of RNA. These results are
representative of three experiments.
Cytokine-induced expression of IL-8 mRNA
Northern blot analysis of mesangial cells stimulated with
IL-la (30 ng/ml) demonstrated significant IL-8 RNA expression
compared with vehicle treated cells (Fig. 2A and B, lanes 1 and
2). In contrast, LPS (10 p.gIml) treated cells did not show
increased expression of IL-8 mRNA compared with vehicle
treated cells (Fig. 2A and B, lanes 1 and 3).
Effect of IL-Ia on mesangial cell-associated IL-8
Having demonstrated that IL-i a induced IL-8 RNA expres-
sion as well as extracellular generation of IL-8 from mesangial
cells, we then carried out immunohistochemical analysis to
determine the effects of IL-la on the synthesis of cell-associ-
ated IL-8 expression by these cells. Figure 3 shows that IL-la
challenged cells displayed intense positive staining for cell-
associated IL-8 (B). The staining was specific for IL-8, since
control preimmune serum was negative (A) and the staining
could be inhibited with excess IL-8 antigen.
Effect of dexamethasone on IL-I a and TNFa induced IL-8
generation by mesangial cells
We next carried out experiments to assess the effects of the
anti-inflammatory agent dexamethasone on the production of
IL-8. Pretreatment of MC with dexamethasone (10 to 300 nM)
for two hours prior to the addition of IL-i a or TNFa resulted in
a weak inhibition of extracellular IL-8 (Fig. 4). Dexamethasone
caused a dose-dependent inhibition of IL-8 generation with
maximum inhibition occurring at 300 flM At this concentration
of dexamethasone, IL-la or TNFa induced generation of IL-8
was reduced by 25% and 38%, respectively (Fig. 4). Interest-
ingly, dexamethasone (300 nM) pretreatment did not signifi-
cantly reduce the expression of IL-8 mRNA induced by IL-i a
(Fig. 2, lanes 2 to 6). Similar data was found for the expression
of IL-8 by MC treated with TNFa plus dexamethasone (data
not shown). These data suggest that post-transcriptional regu-
lation may play an important role in controlling the production
of IL-8 by dexamethasone treated MC.
Discussion
Our findings demonstrate that human mesangial cells, when
stimulated by the appropriate signal, can generate IL-8, a
potent chemotactic cytokine for neutrophils and lymphocytes.
Interleukin 1 and tumor necrosis factor, but not LPS, are very
effective inducers of mesangial cell IL-8 synthesis and release,
as shown by three separate assays. The first assay allowed for
the detection of expression of IL-8 mRNA, the second utilized
immunohistochemical analysis for qualitative determination of
mesangial cell-associated IL-8, and the third assay allowed
quantitation of extracellular IL-8 by the use of a specific
ELISA. Furthermore, treatment of MC with the anti-inflamma-
tory steroid dexamethasone produced only a weak inhibition in
the expression of secreted peptide, in marked contrast to the
pronounced inhibitory effect of lower doses of dexamethasone
on the generation of IL-8 by cytokine stimulated fibroblasts and
monocytes [18, 19].
The regulation of cell to cell communication via released
cytokines is a key event in the initiation and maintenance of
inflammatory states. The two major pro-inflammatory cyto-
kines IL-i and TNF, have been detected in the supernatants of
4!'
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Fig. 3. Photomicrograph of immunohistochemical analysis of IL-i stimulated mesangial cells. A. Control (preimmune) serum demonstrating the
absence of non-specific immunolocalization of IL-8. B. The expression of IL-8 antigen. Cells were fixed and stained as described in the methods,
6 hours post-treatment (x400).
actively proliferating mesangial cells in culture [20, 21]. Fur-
thermore, Werber et al have demonstrated that the interleukin
1 gene is expressed by rat mesangial cells and is augmented in
immune complex glomerulonephritis [22].
Although neutrophil accumulation following a delay has been
reported at the site of intradermal injection of recombinant
IL-la and TNFa in mice [23, 24] and in rabbits [25], in vitro
studies have revealed that IL-la and TNFa fail to stimulate
human PMN locomotion or the elevation of intracellular cal-
cium [18]. To provide an explanation for this paradox we and
others have demonstrated that the neutrophil stimulating activ-
ities of IL-i and TNF are probably due to the generation of
other secreted peptides, such as IL-8 [4], which appear to
confer target cell specificity.
Fig. 4. The effect of dexamethasone on IL-ia
and TNFa induced IL-8 generation by mesangial
cells. Cells were pre-treated with the appropriate
dose of dexamethasone for 2 hours, before the
addition of either TNFa (hatched bars), IL-la
(blocked bars), or LPS (cross hatched bars),
cultures were incubated at 37°C for a further 18
hours, and the supernatants were assayed for
C LPS extracellular IL-8. Data shown are from a
+ + representative experiment, similar results were300 300 obtained in 2 other experiments (all experiments
were carried out in duplicate). Results are the
Dex (nM) mean SEM of quadruple samples.
The identification of mesangial cell derived IL-8, indicates
that the mesangial cells can be active participants in the
inflammatory response via the generation of this chemotactic
cytokine. These observations are important as, the mesangial
cell is well situated to participate in bidirectional communica-
tion between interstitial and vascular events in the kidney.
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